ÂÜÀòÂÒÂ×

Erik Eliasson has a diverse and extensive work experience in the field of clinical pharmacology. Erik began their career in 1997 at Huddinge University Hospital where they completed a houseman program, gaining experience in various medical specializations. During this time, they also conducted research in molecular toxicology at Karolinska Campus.

In 2001, Eliasson took on the role of MD in gastroenterology, hepatology, and nephrology at Karolinska University Hospital. Erik also served as the acting head of the Regional Pharmacovigilance Centre, collaborating with the Medical Products Agency.

Starting in 2004, Eliasson worked as a specialist/senior physician, associate professor, and lecturer in clinical pharmacology at Karolinska University Hospital and Karolinska Institutet. During this period, they also joined AstraZeneca R&D as a research physician, focusing on early clinical studies and drug safety.

In 2016, Eliasson joined the European Medicines Agency as a national expert on secondment, providing scientific and technical support to the agency's Scientific Advice Office. Erik was the single point of contact for applicants seeking scientific advice in drug development, mainly from the pharmaceutical industry.

Since 2017, Eliasson has been the Head of Section for Clinical Support at the Pharmacology Laboratory of Karolinska University Hospital. In this role, they are responsible for organizing and ensuring the quality and strategic development of the laboratory services.

Throughout their career, Eliasson has conducted research on individualized drug treatment, dose adjustments, drug-drug interactions, genetic basis of adverse drug reactions, and treatment failures. Erik also specializes in benefit-risk assessment and recommended monitoring of different treatment options.

Erik Eliasson holds an MD PhD degree from Karolinska Institutet. Their educational focus during this time centered on Medical School, supplemented by a PhD in the field of Regulation of hepatic drug metabolism. No specific start or end dates are mentioned for this educational experience.